Thrombolytic Therapy for Pulmonary Embolism in COVID 19 ARDS: A Case Series

COVID 19 patients have a high incidence of vascular thrombosis which may result in pulmonary thromboembolism. Hence, anticoagulation is recommended as part of treatment strategy. Despite anticoagulation patients may develop PTE. These patients may benefit from thrombolysis. Here we report a study of six COVID 19 patients who had severe ARDS and moderate PTE who received thrombolytic therapy. All these patients recovered without the need for mechanical ventilation and without any bleeding complication.